| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 125.099 | 171.689 | 226.079 | 278.404 | 223.351 | 261.153 | 265.102 | 371.701 |
| Total Income - EUR | - | - | 132.843 | 181.240 | 237.376 | 282.791 | 230.099 | 267.361 | 285.610 | 375.442 |
| Total Expenses - EUR | - | - | 111.836 | 131.699 | 192.299 | 236.318 | 220.041 | 261.871 | 257.282 | 272.498 |
| Gross Profit/Loss - EUR | - | - | 21.008 | 49.541 | 45.077 | 46.474 | 10.059 | 5.490 | 28.329 | 102.944 |
| Net Profit/Loss - EUR | - | - | 19.277 | 47.717 | 42.716 | 43.766 | 8.034 | 3.112 | 25.754 | 93.083 |
| Employees | - | - | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 |
Check the financial reports for the company - Strategic Implant Company Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 2.503 | 1.831 | 24.678 | 20.105 | 14.740 | 8.765 | 33.007 | 25.591 |
| Current Assets | - | - | 72.634 | 148.153 | 193.355 | 320.492 | 326.291 | 238.048 | 255.318 | 320.419 |
| Inventories | - | - | 42.427 | 82.192 | 127.218 | 215.180 | 259.480 | 196.411 | 222.575 | 272.729 |
| Receivables | - | - | 23.358 | 22.038 | 44.280 | 76.540 | 35.575 | 18.408 | 16.044 | 27.379 |
| Cash | - | - | 6.849 | 43.923 | 21.858 | 28.772 | 31.236 | 23.229 | 16.698 | 20.311 |
| Shareholders Funds | - | - | 19.495 | 66.854 | 108.276 | 149.989 | 154.696 | 158.288 | 183.562 | 275.619 |
| Social Capital | - | - | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | - | - | 55.642 | 82.624 | 109.758 | 190.609 | 206.550 | 112.037 | 104.762 | 70.391 |
| Income in Advance | - | - | 0 | 506 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Strategic Implant Company Srl